Table 1.
Ethical guidelines and codes that affect publication practice
| Issuing group and type of statement or code | Website or citation |
|---|---|
| American Medical Writers Association (AMWA). Code of Ethics | http://www.amwa.org/ |
| American Medical Writers Association Position Statement on the Contribution of Medical Writers to Scientific Publications. | http://www.amwa.org/files/About%20Us/AMWA_PositionStatement_Contributions.pdf |
| Committee on Publication Ethics (COPE) | http://publicationethics.org/ |
| CONSORT statement | http://www.consort-statement.org |
| Council of Science Editors (CSE). White paper on Promoting Integrity in Scientific Journal publications | http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3313 |
| EQUATOR network | http://www.equator-network.org/2013/10/31/reporting-guidelines-can-their-use-make-the-work-of-systematic-reviewers-and-guideline-developers-better/ |
| European Medical Writers Association (EMWA). Increasing Author Disclosure Requirements: What Does This Mean For Medical Writers Involved In The Manuscript Development Process? | http://www.emwa.org/Home/Webeditorial-2.html |
| AMWA/EMWA/ISMPP Joint statement on the role of the medical writer | See http://www.ismpp.org |
| GPP3 | See http://www.ismpp.org |
| International Committee of Medical Journal Editors (ICMJE) Recommendations | http://www.icmje.org/recommendations/ |
| International Society for Medical Publication Professionals (ISMPP) Code of Ethics | http://www.ismpp.org/ |
| Medical Publishing Insights & Practices (MPIP) | https://www.mpip-initiative.org/transparencymatters/whytransparencymatters.html |
| The Pharmaceutical Research and Manufacturers of America (PhRMA) Code | http://www.phrma.org/sites/default/files/105/042009_clinical_trial_principles_final.pdf |
| World Association of Medical Editors (WAME) Conflict of Interest in Peer‐Reviewed Medical Journals. | http://www.wame.org/conflict-of-interest-in-peer-reviewed-medical-journals |